173 related articles for article (PubMed ID: 22413537)
21. Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan.
Fujimori K; Tarasawa K; Fushimi K
Blood Purif; 2021; 50(4-5):560-565. PubMed ID: 33582663
[TBL] [Abstract][Full Text] [Related]
22. Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.
Terayama T; Yamakawa K; Umemura Y; Aihara M; Fujimi S
Surg Infect (Larchmt); 2017 Apr; 18(3):225-233. PubMed ID: 28092497
[TBL] [Abstract][Full Text] [Related]
23. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.
Payen DM; Guilhot J; Launey Y; Lukaszewicz AC; Kaaki M; Veber B; Pottecher J; Joannes-Boyau O; Martin-Lefevre L; Jabaudon M; Mimoz O; Coudroy R; Ferrandière M; Kipnis E; Vela C; Chevallier S; Mallat J; Robert R;
Intensive Care Med; 2015 Jun; 41(6):975-84. PubMed ID: 25862039
[TBL] [Abstract][Full Text] [Related]
24. Endotoxin removal: how far from the evidence? From EUPHAS to EUPHRATES.
Rachoin JS; Foster D; Dellinger RP
Contrib Nephrol; 2010; 167():111-118. PubMed ID: 20519905
[TBL] [Abstract][Full Text] [Related]
25. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
[TBL] [Abstract][Full Text] [Related]
26. Identifying Septic Shock Populations Benefitting From Polymyxin B Hemoperfusion: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.
Nakata H; Yamakawa K; Kabata D; Umemura Y; Ogura H; Gando S; Shintani A; Shiraishi A; Saitoh D; Fujishima S; Mayumi T; Kushimoto S; Abe T; Shiino Y; Nakada TA; Tarui T; Hifumi T; Otomo Y; Okamoto K; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S;
Shock; 2020 Nov; 54(5):667-674. PubMed ID: 32195922
[TBL] [Abstract][Full Text] [Related]
27. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
[TBL] [Abstract][Full Text] [Related]
28. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients.
Srisawat N; Tungsanga S; Lumlertgul N; Komaenthammasophon C; Peerapornratana S; Thamrongsat N; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S; Tungsanga K; Kellum JA
Crit Care; 2018 Oct; 22(1):279. PubMed ID: 30367647
[TBL] [Abstract][Full Text] [Related]
29. Polymyxin-B hemoperfusion and endotoxin removal: lessons from a review of the literature.
Cruz DN; de Cal M; Piccinni P; Ronco C
Contrib Nephrol; 2010; 167():77-82. PubMed ID: 20519901
[TBL] [Abstract][Full Text] [Related]
30. Extended Sessions of Polymyxin-B Immobilized Fiber Column Hemoperfusion Ameliorate Renal Outcome and Mortality in Septic Shock with Acute Kidney Injury.
Maekawa H; Negishi K
Blood Purif; 2018; 46(2):81-89. PubMed ID: 29672307
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of postoperative polymyxin B hemoperfusion in secondary peritonitis patients with septic shock: a propensity-matched analysis.
Yuan KC; Wang SY; Yu MC; Hsu YP; Pan HC; Chen YC
Int J Artif Organs; 2017 Feb; 39(12):603-610. PubMed ID: 28165586
[TBL] [Abstract][Full Text] [Related]
33. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
Nakamura T; Suzuki T; Kawagoe Y; Koide H
ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
[TBL] [Abstract][Full Text] [Related]
34. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber.
Ono S; Tsujimoto H; Matsumoto A; Ikuta S; Kinoshita M; Mochizuki H
Am J Surg; 2004 Aug; 188(2):150-6. PubMed ID: 15249240
[TBL] [Abstract][Full Text] [Related]
35. Early induction of PMX-DHP improves oxygenation in severe sepsis patients with acute lung injury.
Suyama H; Kawasaki Y; Morikawa S; Kaneko K; Yamanoue T
Hiroshima J Med Sci; 2008 Dec; 57(3-4):79-84. PubMed ID: 19260559
[TBL] [Abstract][Full Text] [Related]
36. Time to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients.
Takeyama N; Noguchi H; Hirakawa A; Kano H; Morino K; Obata T; Sakamoto T; Tamai F; Ishikura H; Kase Y; Kobayashi M; Naka T; Takahashi Y;
Blood Purif; 2012; 33(4):252-6. PubMed ID: 22472324
[TBL] [Abstract][Full Text] [Related]
37. [Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column].
Kodama M; Tani T; Maekawa K; Hirasawa H; Otsuka T; Takahashi Y; Kaneko M
Nihon Geka Gakkai Zasshi; 1995 May; 96(5):277-85. PubMed ID: 7596338
[TBL] [Abstract][Full Text] [Related]
38. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
[TBL] [Abstract][Full Text] [Related]
39. Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients.
Lee CT; Tu YK; Yeh YC; Chang T; Shih PY; Chao A; Huang HH; Cheng YJ; Yeh YC;
J Crit Care; 2018 Feb; 43():202-206. PubMed ID: 28915395
[TBL] [Abstract][Full Text] [Related]
40. Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients with Septic Shock.
Inoue S; Sakamoto Y; Koami H; Yamada C K; Nagashima F; Miike T; Iwamura T; Obata T
J Nippon Med Sch; 2018; 85(1):39-46. PubMed ID: 29540645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]